ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Prothena Corp. Plc - Ordinary Shares (MM)

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

0.00
0.00
( 0.00% )
更新日時: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

PRTAV 最新ニュース

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

Prothena to Report Third Quarter 2022 Financial Results on November 3rd DUBLIN, Ireland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Participate in Upcoming Healthcare Conferences

Prothena to Participate in Upcoming Healthcare Conferences DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc...

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $35.5 million in the second quarter and $72.9 million...

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Report Second Quarter 2022 Financial Results on August 8th

Prothena to Report Second Quarter 2022 Financial Results on August 8th DUBLIN, Ireland, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, July 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Participate in Jefferies Healthcare Conference

Prothena to Participate in Jefferies Healthcare Conference DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

Prothena Reports First Quarter 2022 Financial Results and Business Highlights

Prothena Reports First Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $37.4 million in the first quarter; quarter-end cash and...

Prothena to Report First Quarter 2022 Financial Results on May 5th

Prothena to Report First Quarter 2022 Financial Results on May 5th DUBLIN, Ireland, April 28, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PRTAV - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0.00
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
XTIAXTI Aerospace Inc
US$ 0.232
(163.64%)
860.53M
HOTHHoth Therapeutics Inc
US$ 1.5011
(83.15%)
57.38M
RIMEAlgorhythm Holdings Inc
US$ 0.2476
(70.99%)
211.53M
INVZWInnoviz Technologies Ltd
US$ 0.2899
(70.53%)
439.68k
MSAIMultiSensor AI Holdings Inc
US$ 3.25
(62.50%)
41.85M
SLRNACELYRIN Inc
US$ 1.94
(-44.41%)
2.57M
AMSTAmesite Inc
US$ 2.63
(-35.06%)
146.37k
LFWDLifeward Ltd
US$ 2.008
(-33.95%)
1.1M
BOXLBoxlight Corporation
US$ 1.21
(-27.98%)
2.53M
HCTIHealthcare Triangle Inc
US$ 1.3642
(-19.75%)
63.4k
XTIAXTI Aerospace Inc
US$ 0.2319
(163.52%)
862.76M
RIMEAlgorhythm Holdings Inc
US$ 0.24955
(72.34%)
212.19M
SVMHSRIVARU Holding Ltd
US$ 0.0691
(49.24%)
166.21M
CDTConduit Pharmaceuticals Inc
US$ 0.1086
(50.21%)
106.08M
CEROCERo Therapeutics Holdings Inc
US$ 0.0531
(25.53%)
83.75M